Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

Richy, Florent, Ethgen, Olivier, Bruyere, Olivier, Reginster, Jean-Yves · 2004 · Osteoporosis International

Abstract

Vitamin D metabolites alphacalcidol and calcitriol (D-hormones) have been investigated for two decades, but few and conflicting results are available from high-quality randomized controlled trials. Our objectives were to provide an evidence-based update quantitatively summarizing their efficacy on bone mineral density (BMD) and fracture rate. We performed a systematic research of any randomized controlled trial containing relevant data, peer review, data extraction and quality scoring blinded for authors and data sources, and comprehensive meta-analyses of the relevant data. Inclusion criteria were: randomized controlled study, calcitriol or alphacalcidol, BMD or fractures in healthy/osteopenic/osteoporotic patients exposed or not to corticosteroids (CS). Analyses were performed in a conservative fashion using professional dedicated softwares and stratified by outcome, target patients, study quality, and control-group type. Results were expressed as effect size (ES) for bone loss or relative risk (RR) for fracture while allocated to D-hormones vs control. Publication bias and robustness were investigated. Of the trials that were retrieved and subsequently reviewed, 17 papers fitted the inclusion criteria and were assessed. Quality scores ranged from 20 to 100%, the mean (standard deviation) being 72 (22)%. Calcitriol and alphacalcidol were found to have the same efficacy on all outcomes at p>0.13. We globally assessed D-hormones effects in preventing bone loss in patients not…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00198-003-1570-5

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 67 references

Cited by

See all 136

Metadata

Authors
Richy, F., Ethgen, O., Bruyere, O., & Reginster, J.-Y.
Affiliations
University of Liège (BE)
Corresponding author
Richy, Florent
Venue
Osteoporosis International
Published
2004-04-01
Volume
15
Issue
4
Pages
301-310
ISSN
  • 0937-941X (ISSN-L)
  • 1433-2965
OpenAlex
W1982131729
Cited by
136
References
67
Citations by year
2025: 2 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 1 · 2015: 10 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
2.48
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Osteoporosis International (publishedVersion)
  • PubMed (publishedVersion)
  • ORBi (University of Liège) (submittedVersion)
Funders
Teva Pharmaceutical Industries
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
Keywords
alfacalcidol, 1,25-dihydroxyvitamin D3, vitamin D metabolites, corticosteroid-induced osteoporosis, primary osteoporosis, bone mineral density, fracture incidence, vertebral fractures, non-vertebral fractures, bone loss prevention, calcium supplementation, treatment efficacy comparison, publication bias, study quality heterogeneity, treatment effect heterogeneity
MeSH terms
Adrenal Cortex Hormones, Adult, Aged, Calcitriol, Female, Humans, Hydroxycholecalciferols, Male, Middle Aged, Osteoporosis, Risk Factors, Bone Density, Randomized Controlled Trials as Topic, Spinal Fractures, Treatment Outcome, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. https://app.cochat.ai/papers/10.1007/s00198-003-1570-5
The paper
Richy, F., Ethgen, O., Bruyere, O., & Reginster, J.-Y. (2004). Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporosis International. https://doi.org/10.1007/s00198-003-1570-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.